mesothelioma

Despite Negative Results, Meso Foundation Grateful for Investment Into Disease

The Meso Foundation released a statement from its executive director, Mary Hesdorffer, APRN, about AstraZeneca’s tremelimumab trial for mesothelioma.
In an AstraZeneca press release issued yesterday, the company states that “DETERMINE, the Phase IIb clinical trial of 10 mg/kg tremelimumab monotherapy in second or third-line treatment of unresectable malignant mesothelioma, did not meet its primary endpoint […]


Sustaining Your Fundraising Event Audience

by Missy Bowles, Fundraise for Meso Event Planner
I started RODs Benefit for Meso a year after I lost my daddy to peritoneal mesothelioma. It started out as a way to keep his memory alive but has since evolved as a way to help others in the mesothelioma community and give back to the Mesothelioma Applied […]



2015 Mesothelioma Research Grant Recipient Interviews – Part 1

In the first of a special two-part series of Meet the Mesothelioma Experts, we interview our 2015 mesothelioma research grant recipients. In this session, we interview grant recipients Dr. Andrea McClatchey of the Massachusetts General Hospital in Boston, Dr. Sean Carlin of Memorial Sloan Kettering Cancer Center in New York, and Dr. Jill Ohar of […]


Five New Mesothelioma Research Projects Funded

We are pleased to announce the funding of five new mesothelioma research projects by the Meso Foundation. To date the Meso Foundation has funded 99 projects amounting to over $9.4 million awarded toward mesothelioma research.
The Meso Foundation’s research program follows a rigorous peer-review system modeled after that of the National Institutes of Health. Each year, […]